Tradename: VARIVAX

Proper Name: Varicella Virus Vaccine Live

Indication: To include safety and immunogenicity data that supports the intramuscular route as an additional route of administration for VARIVAX, and associated product labeling changes.  

VARIVAX is a vaccine indicated for active immunization for the prevention of varicella in individuals 12 months of age and older.

Approval Date: 02/27/2023

Manufacturer: Merck Sharp & Dohme Corp.